Mexico’s Federal Fee for the Safety towards Sanitary Dangers (Cofepris) has issued an alert a couple of falsified model of Limustin, an immunosuppressant drug utilized in transplant drugs.
The counterfeit copies of Landsteiner Scientific’s tacrolimus product shouldn’t be used as they might put sufferers susceptible to critical unintended effects and remedy failure, in accordance with the regulatory authority.
The falsified drugs has a fictitious lot quantity 129B0219 and the expiration date DEC23, and has various different discrepancies with the real product.
The first packaging is translucent in color and the pictogram of a pregnant lady obstructs the textual content, and the lettering one safety seal are in English and blurred. Inside the first packaging there’s a cotton wick, and capsules are white and blue, differing from the real product.
If a distributor or pharmacy has the faux product in inventory, they need to quarantine it and alert the authorities.